Language selection

Search

Patent 2045682 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 2045682
(54) English Title: METHODS OF COATING VIRAL ANTIGENS IN THE PRESENCE OF NONIONIC DETERGENTS AND ACIDIC PH ONTO A SOLID PHASE
(54) French Title: METHODES D'ENROBAGE D'ANTIGENES VIRAUX A UNE PHASE SOLIDE EN PRESENCE DE DETERGENTS NON IONIQUES DANS UNE SOLUTION AYANT UN PH ACIDE
Status: Deemed Abandoned and Beyond the Period of Reinstatement - Pending Response to Notice of Disregarded Communication
Bibliographic Data
(51) International Patent Classification (IPC):
  • C12Q 1/70 (2006.01)
  • G1N 33/569 (2006.01)
(72) Inventors :
  • FRANCIS, BRYAN (United States of America)
(73) Owners :
  • BAXTER INTERNATIONAL INC.
  • BAXTER DIAGNOSTICS INC.
(71) Applicants :
  • BAXTER INTERNATIONAL INC. (Country Unknown)
  • BAXTER DIAGNOSTICS INC. (United States of America)
(74) Agent: MARKS & CLERK
(74) Associate agent:
(45) Issued:
(86) PCT Filing Date: 1990-11-28
(87) Open to Public Inspection: 1991-05-30
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/US1990/006922
(87) International Publication Number: US1990006922
(85) National Entry: 1991-07-26

(30) Application Priority Data:
Application No. Country/Territory Date
443,635 (United States of America) 1989-11-29

Abstracts

English Abstract

2045682 9108311 PCTABS00005
This invention relates to a process to enhance the activity of
viral antigens that are bound to a solid phase. The viral antigens
are coated to a solid phase in the presence of a nonionic
detergeent, such as Triton X-100 or NP40, in a solution having an acidic
pH.


Claims

Note: Claims are shown in the official language in which they were submitted.


WO 91/08311 PCT/US90/06922
- 5 -
I Claim:
1. An active solid phase coated with viral antigen made by the
process comprising:
Coating a solid phase with viral antigen in an acidic suspension
of a nonionic detergent, and a buffer.
2. The active solid phase of Claim 1 wherein the concentration of
said detergent ranges from .2 to 10%.
3. The active solid phase of Claim 1 wherein said solid phase is a
paramagnetic microparticle.
4. The active solid phase of Claim 1 wherein said detergent is NP40
or Triton X-100.
5. The active solid phase of Claim 1 wherein the pH of the
suspension ranges from about 4.0 to 6Ø
6. The active solid phase of Claim 1 wherein the pH is about 5Ø

Description

Note: Descriptions are shown in the official language in which they were submitted.


W O 91/08311 2 ~ 2 PCr/US90/06922
--1--
Methods of Coating Viral Antigens in the Presence of
Nonionic Detergents and Acidic pH onto a Solid Phase
S BACKGROUN~ OF THE INVENTION
1. Field of the Invention
This invention relates to a process to coat viral antigens in
the presence of nonionic detergent and acidic pH, onto a solid
phase, to ennance the activity of bound viral antigens.
1~ 2. ~escription of the Prior Art
AntiDodies are immobilized on solid phases, such as microtiter
- ~lates and latex beads, for use in research and diagnostic assays.
Detection of monoclonal anti~odies to membrane-associated proteins,
however, presents a problem, since nonionic detergents used to
1~ solubilize membrane antigens retard or prevent protein binding to
latex microtiter wells. G. ~rexler et al., pld and Simple
Method for Efficient Coating of Microtiter Plates Using Low Amr,unts
of Antigen in tne ~resence of Detergent, 95 J. Immuno. Metn. 117
~ .
(19~). Garaas et al., Coating of Proteins in the Presence of
2u ~etergents, 10~ J. Immuno. Meth. ~51 (198B). Tnis problem nas been
addressed in the past with a variety of solutions. One investigator
suyyested using glutoraldehyde to immobilize antigen in the presence
of detergent. ~. Evans, 73 J. Immuno. 427 (lY84). Another
investigator suggested the use of Bouin's fluid to increase the
binding of antigen solubili~e with a nonionic detergent. Noteboo~
et al., 7~ J. lmmuno. Meth. 141 (19~4). ~till another investigator
! aisclosed a process to increase the binding of antigen to a
microtiter plate using beads to adsorb the residual nonionic
aeter~ent. ~ee Drexler, supra. One author, however, suggested that
! ~U proteins can De effectively bound to latex surfaces provided that a
detergent witn a nigh critical micelle concentration (CMC), i.e. the
concentration ot a detergent wnich allows the formation of micelles,
is used. ~ee ~araas, supra. This investigator tested the nonionic
:. ,
' - .
:
.
' `: ' ' , :: .

WO 91/08311 PCI~/US90/06922
2~Llai~
detergent, Triton X-lOO, among other detergents, at a concentration
of .~ or .bP and a pH of 9.6. From this experiment, one skilled in
the relevant art would conclude that this nonionic detergent, i.e.
Triton X-lUU, inhioits binding at one of the lowest concentrations
and thus would appear to be a poor choice for use in an immunoassay.
SUM~ARY OF THE INVENTION
This invention relates to a method to increase the concentration
of viral antigen on a solid phase ~y coating the solid phase with
lU viral antigen in the presence of nonionic detergents, sucn as Triton X-lOU or NP4~, in acidic pH.
~ETAILEU ~ESCRIPTION OF rH~ INVENTI~N
Antiyen was diluted into a coating buffer and added to
l~ particles. Tne coatin~ buffer was preferably comprised of 0.1 ~l
acetate, pH ~.U with 5~ NP4U, however, other nonionic detergents,
sucn as Triton X-lUO, can be used. It was observed, however, that
; one nonionic detergent, Tween, did not result in a sufficiently high
concentration of antigen to conduct an immunoassay. The concentra-
2U tion of deter~ent can range from .2% to lO~, with the optimu~
concentration from between about l and lO~b. It was observed that p~
can range from 4.U to 6.U, with the optimum pH at 5Ø
; Exa~ple 1 - Coating of HIV antigen onto magnetic microparticles
using NP4U and acid pH.
l ml of 4 X 108 particles/ml of 3 - 4 micron carboxylated
magnetic particles were pelleted and the supernatent was carefully
removea and discarded. Tne particles were resuspended in l ml of
U.l M acetate buffer, pH S.U, containing ~% NP40 and 250 ug/ml of
HIV antigen. The particles were tumbled end over end at S - 6 rpm
~U o~ernignt at room temperature. The particles were pelleted and
;~ supernatent was discaraed. The particles were resuspended in 1 ml
ot PBS, pelleted and tne su~ernatent was discarded. This was re-
peatea two ~imes. The particles were resuspended in l ml of diluen~
(0.1~ acetate, pH ~.0, U.~M NACl, 1% NaN3) and stored at 2 - ~.
" .
- - , - - . . ~ . , :

WO 91/08311 2 ~ ~ ~ & ~ 2 PCI~/US90/06922
... ;,................................................................ .
-- 3 --
Example 2 - Comparison of coating conditions.
5 ml of solution containing HIV antigen, was dialyzed against
three changes of four liters of 0.1 M acetate pH 5Ø Three
different coating buffers were assessed: Buffer A was comprised of
ù.1 M acetate, at a pH SØ Buffer B was comprised of 0.1 M
acetate, 0.1 M NaCl, at a pH 5Ø Buffer C was comprised of 0.1 M
acetate, 0.1 M NaCl, 0.2~ NP4~, at a pH 5Ø
HIV negative serum was designated "617", positive was designated
"61~", and high positive serum was designated "R-J 1825". These
1~ sera were diluted 1/100 in sample dilution buffer (SDB) (32% calf
serum, ~.02M phosphate, pH 7.4, 0.5M NACl, 1% NP40, and 0.1% NaN3).
- The dialyzed preparation was coated at 1/2 dilution with coating
~uffers A, B, and C on to 1 ml of 2.5% carboxylated paramagnetic
particles (3.~ um). Particles were incubated overnight at 2 Q 8
13 C. The particles were pelleted, the supernatent was discarded, and
tne particles were resuspended in 1% normal goat serum (NGS) in 0.1
M acetate, at a pH 5Ø
, Tne coated particles were incubated for two hours at room
temperature, then washed tnree times with 1 mL isotonic buffered
2u saline (IBS).
; 2uul of particles (1 X 107 parts/mL) were added to 50 ul of
sample (1/1~0 in SBD). Tnis mixture was incubated for 30 minutes at
~ 37C. Tne solid phase was washed to remove unbound material. 50 ul
-1 of goat anti-human beta glactosidase labeled antibody was added to
` 2~ the mixture. This mixture was then incubated for 15 minutes at37C. The mixture was washed to remove unbound antibody and 50 ul
substrate (B-D-galactopyranoside) was added. The fluorescence was
read at 2 and 14 minutes using a Pandex~ FCA instrument. The
results are reported below.
3U
,
:
, ' ', . ! , .
'. . : . ~ . '' ~ ' . ' . '

W O 91/083tl PcT/US9o/o6922
-- 4 --
2 ~ j ~ 8 2
Table _l
S ~ B 617 618 1825
Buffer A U.S 601.3 + 111.7 4329 t7.2) 16191 ~26.9)
~uffer B 3 750.3 + 98.5 4287 (5.7) 19059 t25.4)
Buffer C 0 473 + 36.34096.3 (8.7) 12669 (26.8)
Channel Report: 4U0/450
Gain Setting: lU
Read Time: lUU ms
1U Table 2
s u e ~17 618 1825
_ _
Buffer A 8 7~1.3 + 145.5 5449.7 (7.U) 19738 (2S.3)
~uffer ~ 7.5 970.7 + 130.6 52~7.7 (5.4) 23434 (24.2)
~utfer C U 611.7 + 5Y.5 5136.7 (8.4) 15434 (2~.2)
1~ Cnannel ~eporl: 4UU/4~0
~ain Setting: lU . .
Read Time: lUU ms
Table 3
~U S D B 617 61~ 1825
~uffer A 7.5 1~01120.7 (6.2) 3517 (19.7)
~uffer ~ 4.~ 22u.41000.7 (4.5) 4425 (20.1)
Buffer C U 13B.71040.4 (7.5) 2765 (19.9)
. :
Uelta ~eaa (Ta~le 2 - Table 1) .
'
.
Conclusions
The coating Duffer "C" comprised of 0.1 ~ acetate, û.1 M NACl,
~U and U.~ 40, and resulted in a greater concentration of viral
antiyens on the solia phase. AIDS antigens coated in the presence
of nonionic aetergents and acidic pH resultea in viral coated
~articles witn enhancea activity over particles coated using other
buffers.
:
,: . - -- : . . - - : , . : : : -
': ' '': ~ - . ' : ~ : ' : ' :
., - - , . . .

Representative Drawing

Sorry, the representative drawing for patent document number 2045682 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: IPC from MCD 2006-03-11
Time Limit for Reversal Expired 1994-05-28
Application Not Reinstated by Deadline 1994-05-28
Deemed Abandoned - Failure to Respond to Maintenance Fee Notice 1993-11-29
Inactive: Adhoc Request Documented 1993-11-29
Application Published (Open to Public Inspection) 1991-05-30

Abandonment History

Abandonment Date Reason Reinstatement Date
1993-11-29
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
BAXTER INTERNATIONAL INC.
BAXTER DIAGNOSTICS INC.
Past Owners on Record
BRYAN FRANCIS
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column (Temporarily unavailable). To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Abstract 1991-05-29 1 33
Cover Page 1991-05-29 1 18
Claims 1991-05-29 1 21
Drawings 1991-05-29 1 8
Abstract 1991-05-29 1 38
Descriptions 1991-05-29 4 148
Fees 1992-09-23 1 44